HITI vs. DRTS, CGEN, OM, GNFT, ADVM, LFCR, OBIO, TELO, GALT, and GLSI
Should you be buying High Tide stock or one of its competitors? The main competitors of High Tide include Alpha Tau Medical (DRTS), Compugen (CGEN), Outset Medical (OM), Genfit (GNFT), Adverum Biotechnologies (ADVM), Lifecore Biomedical (LFCR), Orchestra BioMed (OBIO), Telomir Pharmaceuticals (TELO), Galectin Therapeutics (GALT), and Greenwich LifeSciences (GLSI). These companies are all part of the "medical" sector.
Alpha Tau Medical (NASDAQ:DRTS) and High Tide (NASDAQ:HITI) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their profitability, risk, media sentiment, valuation, earnings, institutional ownership, analyst recommendations, dividends and community ranking.
In the previous week, Alpha Tau Medical had 3 more articles in the media than High Tide. MarketBeat recorded 4 mentions for Alpha Tau Medical and 1 mentions for High Tide. High Tide's average media sentiment score of 0.15 beat Alpha Tau Medical's score of 0.00 indicating that Alpha Tau Medical is being referred to more favorably in the media.
High Tide has higher revenue and earnings than Alpha Tau Medical. Alpha Tau Medical is trading at a lower price-to-earnings ratio than High Tide, indicating that it is currently the more affordable of the two stocks.
2.7% of Alpha Tau Medical shares are held by institutional investors. Comparatively, 4.5% of High Tide shares are held by institutional investors. 39.5% of Alpha Tau Medical shares are held by insiders. Comparatively, 12.4% of High Tide shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.
Alpha Tau Medical received 3 more outperform votes than High Tide when rated by MarketBeat users. Likewise, 60.00% of users gave Alpha Tau Medical an outperform vote while only 39.13% of users gave High Tide an outperform vote.
Alpha Tau Medical currently has a consensus price target of $12.00, indicating a potential upside of 324.03%. High Tide has a consensus price target of $4.50, indicating a potential upside of 103.62%. Given High Tide's higher probable upside, research analysts plainly believe Alpha Tau Medical is more favorable than High Tide.
Alpha Tau Medical has a net margin of 0.00% compared to Alpha Tau Medical's net margin of -7.46%. Alpha Tau Medical's return on equity of -2.03% beat High Tide's return on equity.
Alpha Tau Medical has a beta of 0.75, meaning that its share price is 25% less volatile than the S&P 500. Comparatively, High Tide has a beta of 0.44, meaning that its share price is 56% less volatile than the S&P 500.
Summary
Alpha Tau Medical beats High Tide on 9 of the 16 factors compared between the two stocks.
Get High Tide News Delivered to You Automatically
Sign up to receive the latest news and ratings for HITI and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding HITI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
High Tide Competitors List
Related Companies and Tools
